RootPath Brings Collaborators Into the Fold With Origami-Based Synthetic DNA Assembly Method

The Watertown, Massachusetts-based firm is looking to develop T cell-based therapies in China, among other applications.

Related Keywords

China ,Guangzhou ,Guangdong ,Shanghai ,Hebron ,Israel General ,Israel ,Xi Chen ,Zhejiang ,Texas ,United States ,Massachusetts ,Jun Wang ,Henan ,Boston ,Cambridge ,Cambridgeshire ,United Kingdom ,Hangzhou ,Barcelona ,Comunidad Autonoma De Cataluna ,Spain ,Chinese ,Kendall Square ,Cheryl Cui ,Bota Bioscience ,Alena Gros ,Yinqing Li ,Ely Porter ,York University Langone Health ,University Of Texas At Austin ,Gibson ,Institute Of Oncology ,Parker Institute For Cancer Immunotherapy ,Tsinghua University ,Parker Institute ,New York University Langone Health ,Nest Bio Ventures ,Nest Bio ,Sequoia Capital China ,Matrix Partners China ,Twist Bioscience ,